One Organization's Panic is an Other Organization's Profit With the swine flu pandemic grabbing headlines and scaring countries the world over, GlaxoSmithKline says that it expects to reap up to $2.1 billion next year from the sale of a new H1N1 vaccine. And it's already … [Read more...] about $2.1B Swine Flu Vaccination Serum Windfall for Glaxo
Andrew Witty
Glaxo Chinese Joint Venture To Produce Vaccines
Glaxo Aggressively Pursues Asian Vaccine Markets GlaxoSmithKline has aggressively pursued a vaccine-production capability in Asia with a Chinese flu shot joint venture and a new plant in Singapore to make pneumonia vaccines. The company inked an alliance with Shenzhen Neptunus … [Read more...] about Glaxo Chinese Joint Venture To Produce Vaccines
GlaxoSmithKline envisions new research ties to biotechs
What do closer PHARMA ties to Educational Facilities Mean to Independent Research? One of my favorite ePeriodicals, FIERCE BIOTECH, The BioTech Industry's Daily Monitor featured this story by John Carroll today GSK's Witty envisions new research ties to biotechs Anxious to … [Read more...] about GlaxoSmithKline envisions new research ties to biotechs